Search

Another mini phage therapy documentary is out! This one was made by Freethink, is 12 min long, and documents the amazing story of "Paige's Phages" – Pseudomonas phages from Ben Chan's lab at Yale helped a young woman regain her deterioratin

Karin Moelling et al. published a paper this week in Viruses calling for urgent changes in regulation to allow phage therapy to proceed for patients in need. The authors are also championing a petition for the cause — learn more at http://p

A recent re-estimation of annual deaths caused by multidrug-resistant organisms (MDRO) has come up with a number almost 7 times higher than the CDC estimate made in 2010. This suggests a need for better surveillance and reporting systems fo

PhagoMed, a Vienna-based phage therapy company, was just awarded a Phoenix Award. The award honours young and successful companies that serve as role models for high-class research and entrepreneurship in Austria. Congratulations!

Sarah Kronheim et al. published a paper in Nature this week on a new mechanism of chemical phage defense in Streptomyces. Here's a News and Views piece by Martha Clokie and an Ars Technica piece on the work.

Tobi Nagel, founder and president of the nonprofit Phages for Global Health, was selected as a 2018 Moonshot Fellow by the Kravis Leadership Institute. The award recognizes leaders of innovative initiatives that positively impact the lives

The dairy industry has historically seen phages as a threat to productions, but Samuel D. Alcaine, a Cornell professor researching dairy fermentations, makes the point here that phages could also be beneficial to the industry.

Christian Møller-Olsen et al. just published an article in Scientific Reports showing that an E. coli phage can kill its host intracellularly, and that it kills more efficiently when human bladder epithelial cells are present. This corrobor

Lytic phages are usually thought to be best for therapy, but this recent review by Rodrigo Monteiro et al. makes a case for giving temperate phages a second look.

The University of Massachusetts Medical School has an opening for a tenure-track assistant professor position in virology. Apply by May 13, 2019.

#### Welcome to Phage Directory, new labs! Check out the 17 new labs we just added to Phage Directory! We just made our signup process faster, so if you've thought about signing up your lab, now's the time!

Where is the world at with compassionate phage therapy? This week, Dr. Shawna McCallin highlights a new review (co-authored with us at Phage Directory and with Dr. Ben Chan at Yale) of phage case reports published to date. Last week, our re

Dr. Barbara Trautner, Dr. Anthony Maresso and Dr. Frank Ramig We have an exciting new postdoc training and research opportunity recently made possible via the acquisition of a VA Merit Award to discover and develop therapeutic phages to tre

Dr. Jeremy Barr | The Barr Lab The Barr Lab research group is studying bacteriophages within the context of their bacterial and mammalian hosts. We are offering an excellent opportunity to engage in an exciting post-doc position that combin

Irshad Ul Haq, PhD, Assistant Professor, Khyber Pakhtunkhwa, Pakistan We are seeking help/collaboration on phage and host sequencing. We don't have any resources to do the sequencing of these, and therefore would like to connect with someon

TU Delft has just opened a new phage library (Fagenbank) for phage therapy. If you have phages you'd like to see used in medical treatments, reach out to Fagenbank by email at fagenbank@tudelft.nl. This library is an initiative by Dr. Stan

virMine is a new phage bioinformatics tool by Andrea Garretto and colleagues at Loyola University of Chicago. Use virMine to identify viral genomes from raw reads representative of viral or mixed (viral and bacterial) communities. Paper | G

We've been interviewed on the What Matters with Steven Brantley podcast! We talk antibiotic resistance, phage therapy, and Phage Directory. Listen here (64 min).

Sooyeon Song and colleagues have published a new paper showing that E. coli employs both active (lytic and temperate) and inactive phages (a cryptic prophage) to discriminate between nearby strains and control cell-cell contact according to

A Canadian cystic fibrosis patient is looking to become the first in Canada to receive phage therapy. He currently seeks phages for his Burkholderia cepacia infection, and his doctors will have to convince Health Canada to give this a try.